Investor Presentation • Jul 31, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
© Luca Campigotto Detail of Seaclor® component
© 2025 De Nora


Paolo Dellachà CEO

Luca Oglialoro CFO

Chiara Locati Head of IR & ESG
H1 2025 Financial Results Review
Sustainability Journey - Update
Final Remarks
Q&A

G r o w t h a n d P r o f i t a b i l i t y — N e w M a r k e t s A d d M o m e n t u m
KEY FINANCIAL RESULTS ON THE RISE
• +3.8% YoY Revenues (+4.6% @ constant fx)
• +8.1% YoY Adj EBITDA - Margin on Revenues 19.6% (+0.8pp vs H1 2024)
EXECUTION DROVE PERFORMANCES
EXPANDING INTO NEW MARKETS
• PFAS – Water Technologies • LITHIUM Refining – Energy Transition
2025 EBITDA GUIDANCE UPGRADE
SUSTAINABILITY JOURNEY
• ~1.5GWh new PV plants at our Colmar (US), Tamworth (UK) and Mentor (US)*

€415.6 m +3.8% YoY +4.6% @ constant fx
2.8% +180 bps
€81.4m +8.1% YoY 19.6% Adj Ebitda margin
€39.7 m +2.5% YoY 9.5% Net margin
€12.0m €118€ €14.2 m @30 June 2024
€221.5m Revenues +8.2% YoY 21.4% Adj.Ebitda margin
€43.2 m Revenues -17.4% YoY 2.5% Adj.Ebitda margin
WATER TECH
€150.9 m Revenues +5.4% YoY 21.8% Adj.Ebitda margin
BACKLOG
€521.8 m €558 @31 Dec. 2024 ~€380 m Order Intake













DE NORA TETRA® Filtration Municipal | Water Treatment 15 k m3 /h Water Treatment capacity New installation

Shoaiba – Saudi Arabia
DE NORA TETRA® Filtration Municipal | Drinking 25 k m3 /h Clean Water to 4.5 m residents Retrofit

HESS Corp. Stampede Phase IV, USA Sanilec® Industrial | Oil & Gas Upgrade installation



SORB® Filtration

| Massachusetts, US SORB FX Municipal Drinking water PFAS removal: 4.5k m3 /d To be delivered in 2026 |
|
|---|---|
| Pennsylvania, US SORB FX |
Municipal | Drinking water PFAS removal: 2.9k m3 /d To be delivered in 2026





3 . 6 G W D e l i v e r y b y 2 0 2 5 , w i t h P i p e l i n e e x p e c t e d t o G r a d u a l l y T a k e S h a p e


Actively pursued projects in which our partners, and especially those with whom we are closely cooperating, have been having active interactions
It includes approx. €10 m related to Lithium Projects
DE NORA BACKLOG


N A V I G A T I N G A C O M P L E X S C E N A R I O : O U R E N E R G Y T R A N S I T I O N S T R A T E G Y S h a p i n g S t r a t e g i c P a r t n e r s h i p s , T e c h n o l o g y I n n o v a t i o n , a n d N e w S o l u t i o n s




Partnering with leading international solution providers to accelerate our market penetration across geographies and technologies Green Hydrogen Technologies continue Innovation in large scale AWE and AEM
D R A G O N F L Y ® Proprietary electolyzer solution, to address the promising smallscale segment
Developing new Energy Transition / Circular solutions leveraging on our E-Chem aristocracy



H1 -2025 first Contract to supply a plant to recover lithium from used batteries, Japanese Customer

2024 Partnership with Mangrove Lithium to produce Lithium both from mining and used batteries
H1 2025 Financial Results Review
Sustainability Journey - Update
Final Remarks
Q&A


24

+4.3% @ constant fx
Adj. Ebitda Margin


• Revenue trend reflects backlog timeline mainly related to Neom and Stegra projects. FY guidance confirmed
Electrode Technologies Energy Transition

Technologies
S t a b l e i n c i d e n c e o f S G & A C o r p o r a t e a n d R & D c o s t s


• COGS: the decrease in Incidence on Revenues is due to revenues mix
• G&A and Corporate cost increased mainly due to corporate structure enhancement and some inflationary effects.
• R&D: Incidence on revenues broadly in line with H1'24, including non-recurring costs related to the IPCEI grant.




+45% Adj EBITDA underpinned by:




Electrode Technologies Slightly below 2024

Technologies Mid Single-Digit Growth

High Single-Digit Growth
Excluding non-recurring Gigafactory net costs*
17% - 18%
(previous guidance 17%)
H1 2025 Business Achievements
H1 2025 Financial Results Review
Sustainability Journey - Update
Final Remarks
Q&A




New PV installations at our facilities
This will bring the Group's total installed capacity to ~ 5 GWh
GREEN INNOVATION Sustainability Product Scorecard
Open Surprising Paths (EVP*)
H1 2025 Business Achievements
H1 2025 Financial Results Review
Sustainability Journey - Update
Q&A

S o l i d s e t o f r e s u l t s d r i v e G u i d a n c e u p g r a d e , a s w e a d v a n c e g r o u p g r o w t h s t r a t e g i e s


Solid results drive the upgrade in the 2025 profitability guidance, despite a challenging macroeconomic scenario

Core Business is growing and profitable, confirming the positive short and mid-term view

While execution of Green Hydrogen projects is on time, we advance future growth developing strategic partnerships and enhancing our technological solutions

We are actively developing new markets, PFAS treatment and Lithium Refining, leveraging our unparalleled technological leadership

We are pursuing M&A opportunites in the Water Technologies to strengthen our position in the value chain and enter new segments




Nov. 4 9M 2025 Results Conference Call

[email protected] Investor Relations | Overview | De Nora ph: +39 02 2129 2124
| O DE NORA | ||
|---|---|---|
| -- | -- | ----------- |
| (€m) | Q1 2023 | Q2 2023 | H1 2023 | Q3 2023 | 9M 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | H1 2024 | Q3 2024 | 9M 2024 | Q4 2024 | FY 2024 | Q1 2025 | Q2 2025 | H1 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 216.9 | 203.5 | 420.4 | 209.4 | 629.8 | 226.6 | 856.4 | 189.1 | 211.2 | 400.3 | 200.9 | 601.2 | 261.4 | 862.6 | 200.4 | 215.2 | 415.6 |
| YoY Growth (%) | 8.6% | -4.8% | 2.4% | 1.6% | 2.1% | -4.1% | 0.4% | -12.8% | 3.8% | -4.8% | -4.1% | -4.5% | 15.4% | 0.7% | 6.0% | 1.9% | 3.8% |
| Royalties and commissions | (2.2) | (2.7) | (4.9) | (2.3) | (7.2) | (2.3) | (9.5) | (2.0) | (2.5) | (4.5) | (1.9) | (6.4) | (2.9) | (9.3) | (1.8) | (2.0) | (3.8) |
| Cost of goods sold | (138.4) | (131.3) | (269.7) | (140.0) | (409.7) | (146.0) | (555.7) | (120.7) | (140.6) | (261.3) | (137.4) | (398.7) | (176.2) | (574.9) | (129.5) | (139.9) | (269.4) |
| Selling expenses | (7.5) | (7.5) | (15.0) | (7.5) | (22.5) | (7.6) | (30.1) | (8.1) | (7.5) | (15.6) | (7.6) | (23.2) | (8.6) | (31.8) | (8.0) | (8.0) | (16.0) |
| G&A expenses | (11.7) | (12.6) | (24.3) | (13.4) | (37.7) | (14.2) | (51.9) | (12.0) | (12.5) | (24.5) | (12.2) | (36.7) | (13.9) | (50.6) | (12.8) | (12.8) | (25.6) |
| R&D expenses | (3.5) | (3.3) | (6.8) | (3.4) | (10.2) | (5.8) | (16.0) | (4.0) | (4.0) | (8.0) | (4.1) | (12.1) | (2.7) | (14.8) | (3.0) | (2.7) | (5.7) |
| Other operating income (expenses) | 0.5 | (0.9) | (0.4) | 0.9 | 0.5 | 14.5 | 15.0 | 0.9 | 6.0 | 6.9 | 0.6 | 7.5 | (1.2) | 6.3 | (0.4) | 2.7 | 2.3 |
| Corporate costs | (7.2) | (9.0) | (16.2) | (7.2) | (23.4) | (8.4) | (31.8) | (7.5) | (9.2) | (16.7) | (8.1) | (24.8) | (10.9) | (35.7) | (8.9) | (9.7) | (18.6) |
| EBITDA | 46.9 | 36.2 | 83.1 | 36.5 | 119.6 | 56.8 | 176.4 | 35.7 | 40.9 | 76.6 | 30.2 | 106.8 | 45.0 | 151.8 | 36.0 | 42.8 | 78.8 |
| Margin (%) | 21.6% | 17.8% | 19.8% | 17.4% | 19.0% | 25.1% | 20.6% | 18.9% | 19.4% | 19.1% | 15.0% | 17.8% | 17.2% | 17.6% | 18.0% | 19.9% | 19.0% |
| Depreciation and amortization | (7.2) | (7.2) | (14.4) | (7.4) | (21.8) | (8.8) | (30.6) | (8.2) | (8.0) | (16.2) | (8.2) | (24.4) | (9.9) | (34.3) | (9.1) | (8.8) | (17.9) |
| Impairment | - | (1.3) | (1.3) | - | (1.3) | (7.6) | (8.9) | - | - | - | - | - | (0.9) | (0.9) | - | - | - |
| EBIT | 39.7 | 27.7 | 67.4 | 29.1 | 96.5 | 40.4 | 136.9 | 27.5 | 32.9 | 60.4 | 22.0 | 82.4 | 34.2 | 116.6 | 26.9 | 34.0 | 60.9 |
| Margin (%) | 18.3% | 13.6% | 16.0% | 13.9% | 15.3% | 17.8% | 16.0% | 14.5% | 15.6% | 15.1% | 11.0% | 13.7% | 13.1% | 13.5% | 13.4% | 15.8% | 14.7% |
| Share of profit of equity-accounted investees | - | 1.5 | 1.5 | 2.1 | 3.6 | 1.8 | 5.4 | - | (1.9) | (1.9) | 1.5 | (0.4) | 5.0 | 4.6 | - | (0.8) | (0.8) |
| Net Finance income / (expenses) | (3.9) | (0.6) | (4.5) | 131.4 | 126.9 | (4.0) | 122.9 | (0.3) | (1.9) | (2.2) | (4.3) | (6.5) | 3.1 | (3.4) | (2.2) | (4.3) | (6.5) |
| Profit before tax | 35.8 | 28.6 | 64.4 | 162.6 | 227.0 | 38.2 | 265.2 | 27.2 | 29.1 | 56.3 | 19.2 | 75.5 | 42.3 | 117.8 | 24.7 | 28.9 | 53.6 |
| Income taxes | (10.7) | (7.0) | (17.7) | (10.7) | (28.4) | (5.8) | (34.2) | (9.2) | (7.1) | (16.3) | (6.7) | (23.0) | (11.5) | (34.5) | (8.7) | (9.4) | (18.1) |
| Net Result | 25.1 | 21.6 | 46.7 | 151.9 | 198.6 | 32.4 | 231.0 | 18.0 | 22.0 | 40.0 | 12.5 | 52.5 | 30.8 | 83.3 | 16.0 | 19.5 | 35.5 |

| (€m) | '23 Q1 |
'23 Q2 |
'23 Q3 |
'23 Q4 |
'24 Q1 |
'24 Q2 |
'24 Q3 |
'24 Q4 |
'25 Q1 |
'25 Q2 |
'25 Q1 vs |
'25 Q2 vs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| '24 Q1 |
'24 Q2 |
|||||||||||
| REVENUES | 216 9 |
203 5 |
209 4 |
226 6 |
189 1 |
211 2 |
200 9 |
261 4 |
200 4 |
215 2 |
6 0% |
1 9% |
| Electrode Technologies |
118 9 |
112 8 |
121 0 |
111 5 |
92 7 |
112 1 |
117 5 |
131 | 106 8 |
114 7 |
15 2% |
2 3% |
| Energy Transition |
26 6 |
20 7 |
21 3 |
33 6 |
26 6 |
25 7 |
17 9 |
35 0 |
17 7 |
25 5 |
5% -33 |
8% -0 |
| Technologies Water |
71 4 |
70 0 |
67 1 |
81 5 |
69 8 |
73 4 |
65 5 |
95 4 |
9 75 |
0 75 |
8 7% |
2 2% |
| Adj EBITDA |
47 0 |
37 4 |
37 6 |
50 7 |
36 4 |
38 9 |
32 0 |
50 1 |
39 4 |
42 0 |
8 2% |
8 0% |
| Adj EBITDA Margin |
7% 21 |
4% 18 |
0% 18 |
4% 22 |
2% 19 |
4% 18 |
9% 15 |
2% 19 |
7% 19 |
5% 19 |
||
| Electrode Technologies |
31 0 |
29 7 |
28 1 |
29 8 |
25 3 |
23 9 |
25 3 |
27 0 |
24 0 |
23 4 |
1% -5 |
1% -2 |
| Ebitda Adj Margin |
26 1% |
26 3% |
23 2% |
26 7% |
27 3% |
21 3% |
21 5% |
20 6% |
22 5% |
20 4% |
||
| Energy Transition |
5 0 |
0 6 |
1 5 |
4 8 |
(0 6) |
4 0 |
(3 5) |
5 7 |
(1 8) |
2 9 |
200 0% |
-27 5% |
| Ebitda Adj Margin |
18 8% |
2 9% |
7 0% |
14 3% |
-2 3% |
15 6% |
-19 6% |
16 3% |
-10 2% |
11 4% |
||
| Technologies Water |
11 0 |
7 1 |
8 0 |
16 1 |
11 7 |
11 0 |
10 2 |
17 4 |
17 2 |
15 7 |
0% 47 |
7% 42 |
| Ebitda Adj Margin |
4% 15 |
1% 10 |
9% 11 |
8% 19 |
8% 16 |
0% 15 |
6% 15 |
2% 18 |
7% 22 |
9% 20 |

| (€m) | H1 2024 |
H1 2025 |
|---|---|---|
| Sales | 400 3 |
415 6 |
| EBITDA | 76 6 |
78 8 |
| (%) Margin |
1% 19 |
0% 19 |
| (labor legal expenses) Termination costs + |
0 5 |
0 4 |
| Eligible (net of grant) IPCEI GF costs |
- | (0 2) |
| for , and Costs M&A integration reorganization company , |
0 1 |
1 2 |
| business divesture Marine |
(2 3) |
0 8 |
| Fracking business divesture |
- | 0 3 |
| Other non-recurring costs |
0 4 |
0 1 |
| Adj EBITDA |
3 75 |
81 4 |
| (%) Margin |
18 8% |
19 6% |

| (€m) | 2024 FY |
2025 H1 |
|---|---|---|
| Intangible assets |
116 0 |
102 6 |
| , plant and Property equipment |
291 8 |
292 0 |
| Equity-accounted investees |
236 8 |
235 7 |
| Fixed asset |
644 5 |
630 3 |
| Inventories | 255 5 |
248 8 |
| work of advances from Contract in net customers progress, |
36 4 |
27 4 |
| Trade receivables |
173 5 |
162 7 |
| Trade payables |
(116 8) |
(91 1) |
| working capital Operating |
348 6 |
347 7 |
| Other and liabilities current assets |
(78 2) |
(32 6) |
| working capital Net |
270 3 |
315 1 |
| Deferred tax assets |
15 5 |
14 4 |
| Other receivables and financial non-current assets |
11 4 |
10 7 |
| Employee benefits |
(25 9) |
(24 2) |
| for risks and charges Provisions |
(19 9) |
(19 3) |
| Deferred liabilities tax |
(6 0) |
(5 7) |
| Other payables |
(2 9) |
(2 9) |
| Other and liabilities net current asset non |
(27 8) |
(27 0) |
| invested capital Net |
887 0 |
918 4 |
| / Liquidity (Financial Indebtedness) Net current |
207 7 |
146 4 |
| Financial Indebtedness Non-current |
(140 6) |
(134 3) |
| / Liquidity (Financial Indebtedness) Net - ESMA |
67 1 |
12 0 |
| value of financial Fair instruments |
(0 3) |
0 2 |
| / Liquidity (Financial Indebtedness) Net - De Nora |
66 8 |
12 2 |
| Total Equity |
(953 8) |
(930 6) |
| Total sources |
(887 0) |
(918 4) |

| (€m) | H1 2024 |
H1 2025 |
|---|---|---|
| EBITDA | 76 6 |
78 8 |
| on the sale of , plant and and intangible Losses equipment property assets |
(5 7) |
(0 7) |
| Other items non-monetary |
(4 5) |
(2 1) |
| Cash flows generated by before changes working capital operating activities in net |
66 4 |
76 0 |
| Change in inventory |
(17 2) |
(8 2) |
| Change trade receivables and in construction contracts |
(7 2) |
5 9 |
| Change trade payables in |
(16 0) |
(20 2) |
| receivables/payables Change other in |
(0 7) |
(36 9) |
| Cash flows generated by changes working capital in net |
(41 1) |
(59 4) |
| Cash flows by generated operating activities |
25 3 |
16 6 |
| and other financial expense paid Net Interest Net |
(3 0) |
3 2 |
| paid Income taxes |
(8 4) |
(23 5) |
| cash flows generated by Net operating activities |
13 9 |
(3 7) |
| Sales of , plant and and intangible equipment property assets |
6 8 |
1 1 |
| tangible and intangible Investments in assets |
(22 8) |
(28 4) |
| (Investments) financial Divestments in activities |
2 9 |
0 2 |
| cash flows used Net in investing activities |
(13 1) |
(27 0) |
| Share capital increase |
1 1 |
1 4 |
| Shares Treasury |
(26 0) |
- |
| loans/(Repayment) of loans New |
11 5 |
(6 6) |
| (decrease) other financial liabilities Increase in |
(2 0) |
(1 9) |
| Dividends paid |
(24 4) |
(20 7) |
| cash flows by financing generated activities Net |
(39 9) |
(27 8) |
| (decrease) cash and cash equivalents Net increase in |
(39 0) |
(58 4) |
| cash and cash equivalents Opening |
198 5 |
215 9 |
| gains/(losses) Exchange rate |
(1 4) |
(7 9) |
| Closing cash and cash equivalents |
158 0 |
149 6 |
IR CONTACTS
[email protected] Investor Relations | Overview | De Nora
© 2025 De Nora ©Luca Campigotto
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.